Genome Sequencing Stocks On The Rise [Forbes]
Illumina, Inc. (ILMN)
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
illumina.com/company/investor-information.html
Company Research
Source: Forbes
Genome Sequencing Stocks On The Rise Illumina, Inc. Not too long ago, genome sequencing earned most of its coverage in Popular — a far off vision that someday, maybe, might revolutionize the way in which humans walk this earth. Market Value: $43.6 billion Illumina has been on a tear for the last decade with the stock rising from about $40 to $300. Illumina’s has equipment which resides at some 11,000 hospitals, research labs and medical facilities, and more importantly for long term growth, it’s sticky. Ilumina is a cash cow too, Analysts at Bank of America/Merrill Lynch expect Illumina’s recent $1.2 billion acquisition of Pacific Bioscience (PACB) to bolster its position in DNA sequencing through lower costs and increased output. Myriad Genetics Market Value : $2.3 billion Genomics has given rise to a field known as personalized medicine, and one of the leaders in this field is Myriad Genetics. Myriad has a solid franchise in cancer testing with a reputation for accuracy and a large
Show less
Read more
Impact Snapshot
Event Time:
ILMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ILMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
News
- Rapid Growth of Biotechnology and Pharmacogenomics is Stimulating the Growth of the Global Personalized Medicines Market; says TNR, The Niche Research [Yahoo! Finance]Yahoo! Finance
- Genomics Market to be Worth $70.52 Billion by 2031--Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- Illumina, Inc. (NASDAQ: ILMN) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $170.00 price target on the stock.MarketBeat
- Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL [Yahoo! Finance]Yahoo! Finance
- Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAILPR Newswire
ILMN
Earnings
- 5/2/24 - Beat
ILMN
Sec Filings
- 5/8/24 - Form 4
- 5/8/24 - Form 4
- 5/3/24 - Form 8-K/A
- ILMN's page on the SEC website